nodes	percent_of_prediction	percent_of_DWPC	metapath
Sotalol—ADRB2—prostate cancer	0.627	1	CbGaD
Sotalol—Orciprenaline—ADRB2—prostate cancer	0.00147	0.229	CrCbGaD
Sotalol—Esmolol—ADRB2—prostate cancer	0.000802	0.125	CrCbGaD
Sotalol—Ibuprofen—BCL2—prostate cancer	0.000715	0.111	CrCbGaD
Sotalol—Atenolol—ADRB2—prostate cancer	0.000699	0.109	CrCbGaD
Sotalol—Ibuprofen—CXCL8—prostate cancer	0.000574	0.0892	CrCbGaD
Sotalol—Metoprolol—ADRB2—prostate cancer	0.000545	0.0847	CrCbGaD
Sotalol—Metoprolol—CYP2C19—prostate cancer	0.000469	0.0729	CrCbGaD
Sotalol—Isoprenaline—ADRB2—prostate cancer	0.000387	0.0601	CrCbGaD
Sotalol—Isoprenaline—CYP1A1—prostate cancer	0.000332	0.0516	CrCbGaD
Sotalol—Ibuprofen—CYP2C19—prostate cancer	0.000269	0.0418	CrCbGaD
Sotalol—Ibuprofen—PTGS2—prostate cancer	0.000167	0.026	CrCbGaD
Sotalol—Abdominal distension—Doxorubicin—prostate cancer	0.000143	0.000427	CcSEcCtD
Sotalol—Upper respiratory tract infection—Epirubicin—prostate cancer	0.000143	0.000426	CcSEcCtD
Sotalol—Angiopathy—Prednisone—prostate cancer	0.000143	0.000426	CcSEcCtD
Sotalol—Syncope—Docetaxel—prostate cancer	0.000142	0.000425	CcSEcCtD
Sotalol—Pruritus—Estradiol—prostate cancer	0.000142	0.000425	CcSEcCtD
Sotalol—Asthma—Doxorubicin—prostate cancer	0.000142	0.000425	CcSEcCtD
Sotalol—Influenza—Doxorubicin—prostate cancer	0.000142	0.000425	CcSEcCtD
Sotalol—Leukopenia—Docetaxel—prostate cancer	0.000142	0.000424	CcSEcCtD
Sotalol—Eosinophilia—Doxorubicin—prostate cancer	0.000141	0.00042	CcSEcCtD
Sotalol—Arrhythmia—Prednisone—prostate cancer	0.00014	0.00042	CcSEcCtD
Sotalol—Palpitations—Docetaxel—prostate cancer	0.00014	0.000419	CcSEcCtD
Sotalol—Photosensitivity reaction—Epirubicin—prostate cancer	0.00014	0.000419	CcSEcCtD
Sotalol—Paraesthesia—Etoposide—prostate cancer	0.00014	0.000418	CcSEcCtD
Sotalol—Loss of consciousness—Docetaxel—prostate cancer	0.00014	0.000417	CcSEcCtD
Sotalol—Dyspnoea—Etoposide—prostate cancer	0.000139	0.000415	CcSEcCtD
Sotalol—Alopecia—Prednisone—prostate cancer	0.000139	0.000415	CcSEcCtD
Sotalol—Hyperglycaemia—Epirubicin—prostate cancer	0.000139	0.000414	CcSEcCtD
Sotalol—Somnolence—Etoposide—prostate cancer	0.000139	0.000414	CcSEcCtD
Sotalol—Cough—Docetaxel—prostate cancer	0.000139	0.000414	CcSEcCtD
Sotalol—Angina pectoris—Doxorubicin—prostate cancer	0.000138	0.000414	CcSEcCtD
Sotalol—Vertigo—Capecitabine—prostate cancer	0.000138	0.000412	CcSEcCtD
Sotalol—Syncope—Capecitabine—prostate cancer	0.000138	0.000412	CcSEcCtD
Sotalol—Diarrhoea—Estradiol—prostate cancer	0.000138	0.000411	CcSEcCtD
Sotalol—Leukopenia—Capecitabine—prostate cancer	0.000138	0.000411	CcSEcCtD
Sotalol—Hypertension—Docetaxel—prostate cancer	0.000137	0.000409	CcSEcCtD
Sotalol—Drowsiness—Epirubicin—prostate cancer	0.000137	0.000409	CcSEcCtD
Sotalol—Palpitations—Capecitabine—prostate cancer	0.000136	0.000406	CcSEcCtD
Sotalol—Decreased appetite—Etoposide—prostate cancer	0.000136	0.000405	CcSEcCtD
Sotalol—Chest pain—Docetaxel—prostate cancer	0.000135	0.000404	CcSEcCtD
Sotalol—Myalgia—Docetaxel—prostate cancer	0.000135	0.000404	CcSEcCtD
Sotalol—Loss of consciousness—Capecitabine—prostate cancer	0.000135	0.000403	CcSEcCtD
Sotalol—Asthenia—Mitoxantrone—prostate cancer	0.000134	0.000402	CcSEcCtD
Sotalol—Fatigue—Etoposide—prostate cancer	0.000134	0.000401	CcSEcCtD
Sotalol—Neuropathy peripheral—Epirubicin—prostate cancer	0.000134	0.000401	CcSEcCtD
Sotalol—Cough—Capecitabine—prostate cancer	0.000134	0.0004	CcSEcCtD
Sotalol—Pain—Etoposide—prostate cancer	0.000133	0.000398	CcSEcCtD
Sotalol—Dizziness—Estradiol—prostate cancer	0.000133	0.000397	CcSEcCtD
Sotalol—Hypertension—Capecitabine—prostate cancer	0.000133	0.000396	CcSEcCtD
Sotalol—Upper respiratory tract infection—Doxorubicin—prostate cancer	0.000132	0.000395	CcSEcCtD
Sotalol—Myalgia—Capecitabine—prostate cancer	0.000131	0.000391	CcSEcCtD
Sotalol—Chest pain—Capecitabine—prostate cancer	0.000131	0.000391	CcSEcCtD
Sotalol—Anxiety—Capecitabine—prostate cancer	0.00013	0.000389	CcSEcCtD
Sotalol—Photosensitivity reaction—Doxorubicin—prostate cancer	0.00013	0.000388	CcSEcCtD
Sotalol—Oedema—Docetaxel—prostate cancer	0.00013	0.000387	CcSEcCtD
Sotalol—Vision blurred—Prednisone—prostate cancer	0.000129	0.000385	CcSEcCtD
Sotalol—Infection—Docetaxel—prostate cancer	0.000129	0.000384	CcSEcCtD
Sotalol—Hyperglycaemia—Doxorubicin—prostate cancer	0.000128	0.000383	CcSEcCtD
Sotalol—Diarrhoea—Mitoxantrone—prostate cancer	0.000128	0.000383	CcSEcCtD
Sotalol—Vomiting—Estradiol—prostate cancer	0.000128	0.000382	CcSEcCtD
Sotalol—Agranulocytosis—Epirubicin—prostate cancer	0.000128	0.000382	CcSEcCtD
Sotalol—Gastrointestinal pain—Etoposide—prostate cancer	0.000127	0.000381	CcSEcCtD
Sotalol—Shock—Docetaxel—prostate cancer	0.000127	0.000381	CcSEcCtD
Sotalol—Thrombocytopenia—Docetaxel—prostate cancer	0.000127	0.000379	CcSEcCtD
Sotalol—Rash—Estradiol—prostate cancer	0.000127	0.000379	CcSEcCtD
Sotalol—Drowsiness—Doxorubicin—prostate cancer	0.000127	0.000379	CcSEcCtD
Sotalol—Dermatitis—Estradiol—prostate cancer	0.000127	0.000378	CcSEcCtD
Sotalol—Headache—Estradiol—prostate cancer	0.000126	0.000376	CcSEcCtD
Sotalol—Oedema—Capecitabine—prostate cancer	0.000125	0.000375	CcSEcCtD
Sotalol—Bradycardia—Epirubicin—prostate cancer	0.000125	0.000374	CcSEcCtD
Sotalol—Infection—Capecitabine—prostate cancer	0.000125	0.000372	CcSEcCtD
Sotalol—Neuropathy peripheral—Doxorubicin—prostate cancer	0.000124	0.000371	CcSEcCtD
Sotalol—Haemoglobin—Epirubicin—prostate cancer	0.000124	0.000369	CcSEcCtD
Sotalol—Shock—Capecitabine—prostate cancer	0.000123	0.000369	CcSEcCtD
Sotalol—Abdominal pain—Etoposide—prostate cancer	0.000123	0.000368	CcSEcCtD
Sotalol—Body temperature increased—Etoposide—prostate cancer	0.000123	0.000368	CcSEcCtD
Sotalol—Vertigo—Prednisone—prostate cancer	0.000123	0.000367	CcSEcCtD
Sotalol—Haemorrhage—Epirubicin—prostate cancer	0.000123	0.000367	CcSEcCtD
Sotalol—Thrombocytopenia—Capecitabine—prostate cancer	0.000123	0.000367	CcSEcCtD
Sotalol—Syncope—Prednisone—prostate cancer	0.000123	0.000367	CcSEcCtD
Sotalol—Hyperhidrosis—Capecitabine—prostate cancer	0.000121	0.000362	CcSEcCtD
Sotalol—Hypotension—Docetaxel—prostate cancer	0.000121	0.000361	CcSEcCtD
Sotalol—Loss of consciousness—Prednisone—prostate cancer	0.00012	0.000359	CcSEcCtD
Sotalol—Nausea—Estradiol—prostate cancer	0.000119	0.000357	CcSEcCtD
Sotalol—Vomiting—Mitoxantrone—prostate cancer	0.000119	0.000356	CcSEcCtD
Sotalol—Visual impairment—Epirubicin—prostate cancer	0.000119	0.000354	CcSEcCtD
Sotalol—Agranulocytosis—Doxorubicin—prostate cancer	0.000118	0.000353	CcSEcCtD
Sotalol—Hypertension—Prednisone—prostate cancer	0.000118	0.000353	CcSEcCtD
Sotalol—Rash—Mitoxantrone—prostate cancer	0.000118	0.000353	CcSEcCtD
Sotalol—Dermatitis—Mitoxantrone—prostate cancer	0.000118	0.000353	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Docetaxel—prostate cancer	0.000118	0.000352	CcSEcCtD
Sotalol—Headache—Mitoxantrone—prostate cancer	0.000117	0.000351	CcSEcCtD
Sotalol—Hypotension—Capecitabine—prostate cancer	0.000117	0.00035	CcSEcCtD
Sotalol—Insomnia—Docetaxel—prostate cancer	0.000117	0.00035	CcSEcCtD
Sotalol—Myalgia—Prednisone—prostate cancer	0.000117	0.000348	CcSEcCtD
Sotalol—Paraesthesia—Docetaxel—prostate cancer	0.000116	0.000347	CcSEcCtD
Sotalol—Anxiety—Prednisone—prostate cancer	0.000116	0.000347	CcSEcCtD
Sotalol—Bradycardia—Doxorubicin—prostate cancer	0.000116	0.000346	CcSEcCtD
Sotalol—Dyspnoea—Docetaxel—prostate cancer	0.000115	0.000345	CcSEcCtD
Sotalol—Somnolence—Docetaxel—prostate cancer	0.000115	0.000344	CcSEcCtD
Sotalol—Haemoglobin—Doxorubicin—prostate cancer	0.000114	0.000342	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Capecitabine—prostate cancer	0.000114	0.000341	CcSEcCtD
Sotalol—Dyspepsia—Docetaxel—prostate cancer	0.000114	0.000341	CcSEcCtD
Sotalol—Haemorrhage—Doxorubicin—prostate cancer	0.000114	0.00034	CcSEcCtD
Sotalol—Insomnia—Capecitabine—prostate cancer	0.000113	0.000339	CcSEcCtD
Sotalol—Paraesthesia—Capecitabine—prostate cancer	0.000113	0.000336	CcSEcCtD
Sotalol—Decreased appetite—Docetaxel—prostate cancer	0.000113	0.000336	CcSEcCtD
Sotalol—Asthenia—Etoposide—prostate cancer	0.000112	0.000334	CcSEcCtD
Sotalol—Dyspnoea—Capecitabine—prostate cancer	0.000112	0.000334	CcSEcCtD
Sotalol—Oedema—Prednisone—prostate cancer	0.000112	0.000334	CcSEcCtD
Sotalol—Fatigue—Docetaxel—prostate cancer	0.000112	0.000334	CcSEcCtD
Sotalol—Angiopathy—Epirubicin—prostate cancer	0.000112	0.000333	CcSEcCtD
Sotalol—Nausea—Mitoxantrone—prostate cancer	0.000111	0.000332	CcSEcCtD
Sotalol—Infection—Prednisone—prostate cancer	0.000111	0.000331	CcSEcCtD
Sotalol—Pain—Docetaxel—prostate cancer	0.000111	0.000331	CcSEcCtD
Sotalol—Dyspepsia—Capecitabine—prostate cancer	0.00011	0.00033	CcSEcCtD
Sotalol—Pruritus—Etoposide—prostate cancer	0.00011	0.000329	CcSEcCtD
Sotalol—Shock—Prednisone—prostate cancer	0.00011	0.000328	CcSEcCtD
Sotalol—Arrhythmia—Epirubicin—prostate cancer	0.00011	0.000328	CcSEcCtD
Sotalol—Visual impairment—Doxorubicin—prostate cancer	0.00011	0.000328	CcSEcCtD
Sotalol—Decreased appetite—Capecitabine—prostate cancer	0.000109	0.000326	CcSEcCtD
Sotalol—Alopecia—Epirubicin—prostate cancer	0.000109	0.000325	CcSEcCtD
Sotalol—Fatigue—Capecitabine—prostate cancer	0.000108	0.000323	CcSEcCtD
Sotalol—Hyperhidrosis—Prednisone—prostate cancer	0.000108	0.000323	CcSEcCtD
Sotalol—Pain—Capecitabine—prostate cancer	0.000107	0.00032	CcSEcCtD
Sotalol—Diarrhoea—Etoposide—prostate cancer	0.000107	0.000319	CcSEcCtD
Sotalol—Gastrointestinal pain—Docetaxel—prostate cancer	0.000106	0.000316	CcSEcCtD
Sotalol—Flatulence—Epirubicin—prostate cancer	0.000106	0.000315	CcSEcCtD
Sotalol—Dysgeusia—Epirubicin—prostate cancer	0.000105	0.000313	CcSEcCtD
Sotalol—Back pain—Epirubicin—prostate cancer	0.000104	0.000309	CcSEcCtD
Sotalol—Angiopathy—Doxorubicin—prostate cancer	0.000103	0.000308	CcSEcCtD
Sotalol—Dizziness—Etoposide—prostate cancer	0.000103	0.000308	CcSEcCtD
Sotalol—Muscle spasms—Epirubicin—prostate cancer	0.000103	0.000307	CcSEcCtD
Sotalol—Gastrointestinal pain—Capecitabine—prostate cancer	0.000103	0.000306	CcSEcCtD
Sotalol—Abdominal pain—Docetaxel—prostate cancer	0.000102	0.000306	CcSEcCtD
Sotalol—Body temperature increased—Docetaxel—prostate cancer	0.000102	0.000306	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Prednisone—prostate cancer	0.000102	0.000304	CcSEcCtD
Sotalol—Arrhythmia—Doxorubicin—prostate cancer	0.000102	0.000304	CcSEcCtD
Sotalol—Insomnia—Prednisone—prostate cancer	0.000101	0.000302	CcSEcCtD
Sotalol—Vision blurred—Epirubicin—prostate cancer	0.000101	0.000301	CcSEcCtD
Sotalol—Alopecia—Doxorubicin—prostate cancer	0.000101	0.0003	CcSEcCtD
Sotalol—Paraesthesia—Prednisone—prostate cancer	0.0001	0.0003	CcSEcCtD
Sotalol—Abdominal pain—Capecitabine—prostate cancer	9.92e-05	0.000296	CcSEcCtD
Sotalol—Body temperature increased—Capecitabine—prostate cancer	9.92e-05	0.000296	CcSEcCtD
Sotalol—Vomiting—Etoposide—prostate cancer	9.91e-05	0.000296	CcSEcCtD
Sotalol—Dyspepsia—Prednisone—prostate cancer	9.83e-05	0.000294	CcSEcCtD
Sotalol—Rash—Etoposide—prostate cancer	9.83e-05	0.000294	CcSEcCtD
Sotalol—Dermatitis—Etoposide—prostate cancer	9.82e-05	0.000293	CcSEcCtD
Sotalol—Headache—Etoposide—prostate cancer	9.77e-05	0.000292	CcSEcCtD
Sotalol—Flatulence—Doxorubicin—prostate cancer	9.76e-05	0.000292	CcSEcCtD
Sotalol—Decreased appetite—Prednisone—prostate cancer	9.71e-05	0.00029	CcSEcCtD
Sotalol—Dysgeusia—Doxorubicin—prostate cancer	9.7e-05	0.00029	CcSEcCtD
Sotalol—Fatigue—Prednisone—prostate cancer	9.63e-05	0.000288	CcSEcCtD
Sotalol—Vertigo—Epirubicin—prostate cancer	9.62e-05	0.000287	CcSEcCtD
Sotalol—Syncope—Epirubicin—prostate cancer	9.6e-05	0.000287	CcSEcCtD
Sotalol—Leukopenia—Epirubicin—prostate cancer	9.58e-05	0.000286	CcSEcCtD
Sotalol—Back pain—Doxorubicin—prostate cancer	9.58e-05	0.000286	CcSEcCtD
Sotalol—Muscle spasms—Doxorubicin—prostate cancer	9.52e-05	0.000284	CcSEcCtD
Sotalol—Palpitations—Epirubicin—prostate cancer	9.46e-05	0.000283	CcSEcCtD
Sotalol—Loss of consciousness—Epirubicin—prostate cancer	9.41e-05	0.000281	CcSEcCtD
Sotalol—Cough—Epirubicin—prostate cancer	9.34e-05	0.000279	CcSEcCtD
Sotalol—Vision blurred—Doxorubicin—prostate cancer	9.34e-05	0.000279	CcSEcCtD
Sotalol—Asthenia—Docetaxel—prostate cancer	9.29e-05	0.000278	CcSEcCtD
Sotalol—Nausea—Etoposide—prostate cancer	9.26e-05	0.000277	CcSEcCtD
Sotalol—Hypertension—Epirubicin—prostate cancer	9.24e-05	0.000276	CcSEcCtD
Sotalol—Pruritus—Docetaxel—prostate cancer	9.17e-05	0.000274	CcSEcCtD
Sotalol—Gastrointestinal pain—Prednisone—prostate cancer	9.14e-05	0.000273	CcSEcCtD
Sotalol—Chest pain—Epirubicin—prostate cancer	9.12e-05	0.000272	CcSEcCtD
Sotalol—Myalgia—Epirubicin—prostate cancer	9.12e-05	0.000272	CcSEcCtD
Sotalol—Anxiety—Epirubicin—prostate cancer	9.08e-05	0.000271	CcSEcCtD
Sotalol—Asthenia—Capecitabine—prostate cancer	9e-05	0.000269	CcSEcCtD
Sotalol—Vertigo—Doxorubicin—prostate cancer	8.9e-05	0.000266	CcSEcCtD
Sotalol—Syncope—Doxorubicin—prostate cancer	8.88e-05	0.000265	CcSEcCtD
Sotalol—Pruritus—Capecitabine—prostate cancer	8.87e-05	0.000265	CcSEcCtD
Sotalol—Leukopenia—Doxorubicin—prostate cancer	8.87e-05	0.000265	CcSEcCtD
Sotalol—Diarrhoea—Docetaxel—prostate cancer	8.86e-05	0.000265	CcSEcCtD
Sotalol—Abdominal pain—Prednisone—prostate cancer	8.83e-05	0.000264	CcSEcCtD
Sotalol—Body temperature increased—Prednisone—prostate cancer	8.83e-05	0.000264	CcSEcCtD
Sotalol—Palpitations—Doxorubicin—prostate cancer	8.75e-05	0.000261	CcSEcCtD
Sotalol—Oedema—Epirubicin—prostate cancer	8.74e-05	0.000261	CcSEcCtD
Sotalol—Loss of consciousness—Doxorubicin—prostate cancer	8.71e-05	0.00026	CcSEcCtD
Sotalol—Infection—Epirubicin—prostate cancer	8.68e-05	0.000259	CcSEcCtD
Sotalol—Cough—Doxorubicin—prostate cancer	8.64e-05	0.000258	CcSEcCtD
Sotalol—Shock—Epirubicin—prostate cancer	8.6e-05	0.000257	CcSEcCtD
Sotalol—Diarrhoea—Capecitabine—prostate cancer	8.58e-05	0.000256	CcSEcCtD
Sotalol—Dizziness—Docetaxel—prostate cancer	8.57e-05	0.000256	CcSEcCtD
Sotalol—Thrombocytopenia—Epirubicin—prostate cancer	8.56e-05	0.000255	CcSEcCtD
Sotalol—Hypertension—Doxorubicin—prostate cancer	8.55e-05	0.000255	CcSEcCtD
Sotalol—Hyperhidrosis—Epirubicin—prostate cancer	8.45e-05	0.000252	CcSEcCtD
Sotalol—Myalgia—Doxorubicin—prostate cancer	8.43e-05	0.000252	CcSEcCtD
Sotalol—Chest pain—Doxorubicin—prostate cancer	8.43e-05	0.000252	CcSEcCtD
Sotalol—Anxiety—Doxorubicin—prostate cancer	8.4e-05	0.000251	CcSEcCtD
Sotalol—Dizziness—Capecitabine—prostate cancer	8.29e-05	0.000248	CcSEcCtD
Sotalol—Vomiting—Docetaxel—prostate cancer	8.24e-05	0.000246	CcSEcCtD
Sotalol—Rash—Docetaxel—prostate cancer	8.17e-05	0.000244	CcSEcCtD
Sotalol—Hypotension—Epirubicin—prostate cancer	8.17e-05	0.000244	CcSEcCtD
Sotalol—Dermatitis—Docetaxel—prostate cancer	8.16e-05	0.000244	CcSEcCtD
Sotalol—Headache—Docetaxel—prostate cancer	8.12e-05	0.000242	CcSEcCtD
Sotalol—Oedema—Doxorubicin—prostate cancer	8.09e-05	0.000241	CcSEcCtD
Sotalol—Infection—Doxorubicin—prostate cancer	8.03e-05	0.00024	CcSEcCtD
Sotalol—Asthenia—Prednisone—prostate cancer	8.02e-05	0.000239	CcSEcCtD
Sotalol—Vomiting—Capecitabine—prostate cancer	7.97e-05	0.000238	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Epirubicin—prostate cancer	7.96e-05	0.000238	CcSEcCtD
Sotalol—Shock—Doxorubicin—prostate cancer	7.95e-05	0.000238	CcSEcCtD
Sotalol—Thrombocytopenia—Doxorubicin—prostate cancer	7.92e-05	0.000236	CcSEcCtD
Sotalol—Rash—Capecitabine—prostate cancer	7.91e-05	0.000236	CcSEcCtD
Sotalol—Pruritus—Prednisone—prostate cancer	7.9e-05	0.000236	CcSEcCtD
Sotalol—Insomnia—Epirubicin—prostate cancer	7.9e-05	0.000236	CcSEcCtD
Sotalol—Dermatitis—Capecitabine—prostate cancer	7.9e-05	0.000236	CcSEcCtD
Sotalol—Headache—Capecitabine—prostate cancer	7.86e-05	0.000235	CcSEcCtD
Sotalol—Paraesthesia—Epirubicin—prostate cancer	7.85e-05	0.000234	CcSEcCtD
Sotalol—Hyperhidrosis—Doxorubicin—prostate cancer	7.82e-05	0.000233	CcSEcCtD
Sotalol—Dyspnoea—Epirubicin—prostate cancer	7.79e-05	0.000233	CcSEcCtD
Sotalol—Somnolence—Epirubicin—prostate cancer	7.77e-05	0.000232	CcSEcCtD
Sotalol—Nausea—Docetaxel—prostate cancer	7.7e-05	0.00023	CcSEcCtD
Sotalol—Dyspepsia—Epirubicin—prostate cancer	7.69e-05	0.00023	CcSEcCtD
Sotalol—Diarrhoea—Prednisone—prostate cancer	7.64e-05	0.000228	CcSEcCtD
Sotalol—Decreased appetite—Epirubicin—prostate cancer	7.6e-05	0.000227	CcSEcCtD
Sotalol—Hypotension—Doxorubicin—prostate cancer	7.56e-05	0.000226	CcSEcCtD
Sotalol—Fatigue—Epirubicin—prostate cancer	7.53e-05	0.000225	CcSEcCtD
Sotalol—Pain—Epirubicin—prostate cancer	7.47e-05	0.000223	CcSEcCtD
Sotalol—Nausea—Capecitabine—prostate cancer	7.45e-05	0.000222	CcSEcCtD
Sotalol—Dizziness—Prednisone—prostate cancer	7.39e-05	0.000221	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Doxorubicin—prostate cancer	7.37e-05	0.00022	CcSEcCtD
Sotalol—Insomnia—Doxorubicin—prostate cancer	7.31e-05	0.000218	CcSEcCtD
Sotalol—Paraesthesia—Doxorubicin—prostate cancer	7.26e-05	0.000217	CcSEcCtD
Sotalol—Dyspnoea—Doxorubicin—prostate cancer	7.21e-05	0.000215	CcSEcCtD
Sotalol—Somnolence—Doxorubicin—prostate cancer	7.19e-05	0.000215	CcSEcCtD
Sotalol—Gastrointestinal pain—Epirubicin—prostate cancer	7.15e-05	0.000213	CcSEcCtD
Sotalol—Dyspepsia—Doxorubicin—prostate cancer	7.12e-05	0.000213	CcSEcCtD
Sotalol—Vomiting—Prednisone—prostate cancer	7.1e-05	0.000212	CcSEcCtD
Sotalol—Rash—Prednisone—prostate cancer	7.04e-05	0.00021	CcSEcCtD
Sotalol—Dermatitis—Prednisone—prostate cancer	7.04e-05	0.00021	CcSEcCtD
Sotalol—Decreased appetite—Doxorubicin—prostate cancer	7.03e-05	0.00021	CcSEcCtD
Sotalol—Headache—Prednisone—prostate cancer	7e-05	0.000209	CcSEcCtD
Sotalol—Fatigue—Doxorubicin—prostate cancer	6.97e-05	0.000208	CcSEcCtD
Sotalol—Pain—Doxorubicin—prostate cancer	6.91e-05	0.000206	CcSEcCtD
Sotalol—Abdominal pain—Epirubicin—prostate cancer	6.91e-05	0.000206	CcSEcCtD
Sotalol—Body temperature increased—Epirubicin—prostate cancer	6.91e-05	0.000206	CcSEcCtD
Sotalol—Nausea—Prednisone—prostate cancer	6.64e-05	0.000198	CcSEcCtD
Sotalol—Gastrointestinal pain—Doxorubicin—prostate cancer	6.61e-05	0.000197	CcSEcCtD
Sotalol—Abdominal pain—Doxorubicin—prostate cancer	6.39e-05	0.000191	CcSEcCtD
Sotalol—Body temperature increased—Doxorubicin—prostate cancer	6.39e-05	0.000191	CcSEcCtD
Sotalol—Asthenia—Epirubicin—prostate cancer	6.27e-05	0.000187	CcSEcCtD
Sotalol—Pruritus—Epirubicin—prostate cancer	6.18e-05	0.000185	CcSEcCtD
Sotalol—Diarrhoea—Epirubicin—prostate cancer	5.98e-05	0.000179	CcSEcCtD
Sotalol—Asthenia—Doxorubicin—prostate cancer	5.8e-05	0.000173	CcSEcCtD
Sotalol—Dizziness—Epirubicin—prostate cancer	5.78e-05	0.000173	CcSEcCtD
Sotalol—Pruritus—Doxorubicin—prostate cancer	5.72e-05	0.000171	CcSEcCtD
Sotalol—Vomiting—Epirubicin—prostate cancer	5.56e-05	0.000166	CcSEcCtD
Sotalol—Diarrhoea—Doxorubicin—prostate cancer	5.53e-05	0.000165	CcSEcCtD
Sotalol—Rash—Epirubicin—prostate cancer	5.51e-05	0.000165	CcSEcCtD
Sotalol—Dermatitis—Epirubicin—prostate cancer	5.5e-05	0.000164	CcSEcCtD
Sotalol—Headache—Epirubicin—prostate cancer	5.47e-05	0.000163	CcSEcCtD
Sotalol—Dizziness—Doxorubicin—prostate cancer	5.35e-05	0.00016	CcSEcCtD
Sotalol—Nausea—Epirubicin—prostate cancer	5.19e-05	0.000155	CcSEcCtD
Sotalol—Vomiting—Doxorubicin—prostate cancer	5.14e-05	0.000154	CcSEcCtD
Sotalol—Rash—Doxorubicin—prostate cancer	5.1e-05	0.000152	CcSEcCtD
Sotalol—Dermatitis—Doxorubicin—prostate cancer	5.09e-05	0.000152	CcSEcCtD
Sotalol—Headache—Doxorubicin—prostate cancer	5.07e-05	0.000151	CcSEcCtD
Sotalol—Nausea—Doxorubicin—prostate cancer	4.8e-05	0.000143	CcSEcCtD
Sotalol—ADRB2—Signaling Pathways—MC2R—prostate cancer	2.6e-05	0.000831	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—PTHLH—prostate cancer	2.58e-05	0.000826	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—PRKACB—prostate cancer	2.53e-05	0.000809	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—PTHLH—prostate cancer	2.53e-05	0.000808	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—CALCA—prostate cancer	2.5e-05	0.000801	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—PRKACB—prostate cancer	2.47e-05	0.000791	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—PPP3CA—prostate cancer	2.46e-05	0.000788	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—CALCA—prostate cancer	2.45e-05	0.000784	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—CXCL12—prostate cancer	2.45e-05	0.000782	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—ANXA1—prostate cancer	2.43e-05	0.000777	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—PPP3CA—prostate cancer	2.41e-05	0.000771	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—CXCL12—prostate cancer	2.39e-05	0.000765	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—ANXA1—prostate cancer	2.38e-05	0.00076	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PENK—prostate cancer	2.37e-05	0.000757	CbGpPWpGaD
Sotalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—prostate cancer	2.35e-05	0.000753	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PENK—prostate cancer	2.32e-05	0.000741	CbGpPWpGaD
Sotalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—prostate cancer	2.3e-05	0.000737	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—CALCA—prostate cancer	2.27e-05	0.000727	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—GHR—prostate cancer	2.26e-05	0.000723	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—PRKCQ—prostate cancer	2.23e-05	0.000714	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—CALCA—prostate cancer	2.22e-05	0.000712	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—CXCL12—prostate cancer	2.22e-05	0.000711	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—GHR—prostate cancer	2.21e-05	0.000707	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—PRKCQ—prostate cancer	2.18e-05	0.000698	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—CXCL12—prostate cancer	2.17e-05	0.000695	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—NRP1—prostate cancer	2.17e-05	0.000693	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—NRP1—prostate cancer	2.12e-05	0.000678	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—ADRB2—prostate cancer	2.1e-05	0.000671	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—VAV3—prostate cancer	2.05e-05	0.000655	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—PRKCQ—prostate cancer	2.03e-05	0.000648	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—GNRH1—prostate cancer	2.01e-05	0.000644	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—VIP—prostate cancer	2.01e-05	0.000644	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—VAV3—prostate cancer	2e-05	0.00064	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—ITPR1—prostate cancer	1.98e-05	0.000635	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—PRKCQ—prostate cancer	1.98e-05	0.000634	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—VIP—prostate cancer	1.97e-05	0.00063	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—GNRH1—prostate cancer	1.97e-05	0.00063	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—LPAR1—prostate cancer	1.95e-05	0.000624	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—GRP—prostate cancer	1.95e-05	0.000624	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—ITPR1—prostate cancer	1.94e-05	0.000621	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PLCB2—prostate cancer	1.93e-05	0.000617	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—LRP2—prostate cancer	1.93e-05	0.000617	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—GRP—prostate cancer	1.91e-05	0.00061	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—LPAR1—prostate cancer	1.91e-05	0.00061	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—ADRB2—prostate cancer	1.91e-05	0.00061	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CX3CL1—prostate cancer	1.89e-05	0.000606	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—P4HB—prostate cancer	1.89e-05	0.000606	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PLCB2—prostate cancer	1.89e-05	0.000604	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—LRP2—prostate cancer	1.89e-05	0.000604	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—VAV3—prostate cancer	1.86e-05	0.000594	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—HIST1H2BG—prostate cancer	1.86e-05	0.000594	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—P4HB—prostate cancer	1.85e-05	0.000592	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CX3CL1—prostate cancer	1.85e-05	0.000592	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—GRB7—prostate cancer	1.84e-05	0.000589	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PDE4D—prostate cancer	1.84e-05	0.000589	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—VAV3—prostate cancer	1.82e-05	0.000581	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—HIST1H2BG—prostate cancer	1.82e-05	0.000581	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—ITPR1—prostate cancer	1.8e-05	0.000577	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—GRB7—prostate cancer	1.8e-05	0.000576	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PDE4D—prostate cancer	1.8e-05	0.000576	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—HIST1H4H—prostate cancer	1.79e-05	0.000574	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—CXCL8—prostate cancer	1.79e-05	0.000574	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—ITPR1—prostate cancer	1.76e-05	0.000564	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—HIST1H4H—prostate cancer	1.76e-05	0.000562	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—CXCL8—prostate cancer	1.75e-05	0.000561	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—GNG5—prostate cancer	1.75e-05	0.00056	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—GNG5—prostate cancer	1.71e-05	0.000548	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PTHLH—prostate cancer	1.53e-05	0.000488	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—TGFBR1—prostate cancer	1.53e-05	0.000488	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—AKR1C3—prostate cancer	1.5e-05	0.00048	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PRKACB—prostate cancer	1.49e-05	0.000478	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PTHLH—prostate cancer	1.49e-05	0.000477	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—TGFBR1—prostate cancer	1.49e-05	0.000477	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—AKR1C3—prostate cancer	1.47e-05	0.00047	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PRKACB—prostate cancer	1.46e-05	0.000467	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—THBS1—prostate cancer	1.46e-05	0.000466	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PPP3CA—prostate cancer	1.46e-05	0.000466	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—ANXA1—prostate cancer	1.43e-05	0.000459	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—THBS1—prostate cancer	1.42e-05	0.000455	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PPP3CA—prostate cancer	1.42e-05	0.000455	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PRKCZ—prostate cancer	1.41e-05	0.00045	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—ANXA1—prostate cancer	1.4e-05	0.000449	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PRKCZ—prostate cancer	1.38e-05	0.000441	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—PIK3CG—prostate cancer	1.38e-05	0.00044	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—FGFR4—prostate cancer	1.36e-05	0.000435	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PARP1—prostate cancer	1.36e-05	0.000435	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—PIK3CG—prostate cancer	1.35e-05	0.000431	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CALCA—prostate cancer	1.34e-05	0.00043	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PARP1—prostate cancer	1.33e-05	0.000426	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—FGFR4—prostate cancer	1.33e-05	0.000426	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CALCA—prostate cancer	1.31e-05	0.00042	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CXCL12—prostate cancer	1.31e-05	0.00042	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CXCL12—prostate cancer	1.28e-05	0.000411	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—PIK3CG—prostate cancer	1.25e-05	0.0004	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CASP9—prostate cancer	1.24e-05	0.000395	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—PIK3CG—prostate cancer	1.22e-05	0.000391	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—PIK3CD—prostate cancer	1.21e-05	0.000387	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CASP9—prostate cancer	1.21e-05	0.000387	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PRKCQ—prostate cancer	1.2e-05	0.000383	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—NGFR—prostate cancer	1.2e-05	0.000383	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—PIK3CD—prostate cancer	1.18e-05	0.000379	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—MAP3K7—prostate cancer	1.18e-05	0.000378	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—NGFR—prostate cancer	1.17e-05	0.000375	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PRKCQ—prostate cancer	1.17e-05	0.000375	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—MAP3K7—prostate cancer	1.16e-05	0.00037	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—FGF10—prostate cancer	1.14e-05	0.000364	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—ADRB2—prostate cancer	1.13e-05	0.00036	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—FGF10—prostate cancer	1.11e-05	0.000356	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—JAK2—prostate cancer	1.11e-05	0.000355	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—MAP2K1—prostate cancer	1.11e-05	0.000354	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—PIK3CD—prostate cancer	1.1e-05	0.000351	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—VAV3—prostate cancer	1.1e-05	0.000351	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—JAK2—prostate cancer	1.09e-05	0.000347	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—TGFBR2—prostate cancer	1.08e-05	0.000346	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—MAP2K1—prostate cancer	1.08e-05	0.000346	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—PIK3CD—prostate cancer	1.07e-05	0.000344	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—VAV3—prostate cancer	1.07e-05	0.000344	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—ITPR1—prostate cancer	1.06e-05	0.000341	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—TGFBR2—prostate cancer	1.06e-05	0.000339	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—PIK3CB—prostate cancer	1.05e-05	0.000337	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—ITPR1—prostate cancer	1.04e-05	0.000333	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—PIK3CB—prostate cancer	1.03e-05	0.00033	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—IGF1R—prostate cancer	1.02e-05	0.000326	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—CXCL8—prostate cancer	1.01e-05	0.000324	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—JAK2—prostate cancer	1.01e-05	0.000323	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—IGF1R—prostate cancer	9.96e-06	0.000319	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—CXCL8—prostate cancer	9.91e-06	0.000317	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—JAK2—prostate cancer	9.86e-06	0.000316	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—LPL—prostate cancer	9.76e-06	0.000312	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—IL2—prostate cancer	9.69e-06	0.00031	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PDGFRB—prostate cancer	9.67e-06	0.000309	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—PIK3CB—prostate cancer	9.58e-06	0.000306	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—LPL—prostate cancer	9.55e-06	0.000305	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—IL2—prostate cancer	9.47e-06	0.000303	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PDGFRB—prostate cancer	9.46e-06	0.000303	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—ITGB3—prostate cancer	9.43e-06	0.000302	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—PIK3CB—prostate cancer	9.37e-06	0.0003	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—ITGB3—prostate cancer	9.22e-06	0.000295	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—CXCL8—prostate cancer	9.2e-06	0.000294	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—ERBB3—prostate cancer	9.14e-06	0.000292	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—FGFR2—prostate cancer	9.13e-06	0.000292	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—CXCL8—prostate cancer	9e-06	0.000288	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—ERBB3—prostate cancer	8.94e-06	0.000286	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—FGFR2—prostate cancer	8.93e-06	0.000286	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—IL2—prostate cancer	8.8e-06	0.000281	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—TERT—prostate cancer	8.76e-06	0.00028	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—IL2—prostate cancer	8.6e-06	0.000275	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—TERT—prostate cancer	8.57e-06	0.000274	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—HIF1A—prostate cancer	8.38e-06	0.000268	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—HIF1A—prostate cancer	8.2e-06	0.000262	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—LEP—prostate cancer	8.18e-06	0.000262	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CAV1—prostate cancer	8.11e-06	0.000259	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—KDR—prostate cancer	8.01e-06	0.000256	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—LEP—prostate cancer	8e-06	0.000256	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CAV1—prostate cancer	7.93e-06	0.000254	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—KDR—prostate cancer	7.84e-06	0.000251	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—ESR1—prostate cancer	7.81e-06	0.00025	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—ESR1—prostate cancer	7.64e-06	0.000244	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—BAD—prostate cancer	7.62e-06	0.000244	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—BAD—prostate cancer	7.46e-06	0.000239	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PIK3CG—prostate cancer	7.38e-06	0.000236	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—APC—prostate cancer	7.38e-06	0.000236	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—IRS1—prostate cancer	7.3e-06	0.000233	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—EGF—prostate cancer	7.3e-06	0.000233	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PIK3CG—prostate cancer	7.22e-06	0.000231	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—APC—prostate cancer	7.22e-06	0.000231	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—EGF—prostate cancer	7.14e-06	0.000228	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—IRS1—prostate cancer	7.14e-06	0.000228	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—GSK3B—prostate cancer	7.08e-06	0.000227	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—INS—prostate cancer	6.99e-06	0.000224	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—GSK3B—prostate cancer	6.93e-06	0.000222	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CREBBP—prostate cancer	6.85e-06	0.000219	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—INS—prostate cancer	6.84e-06	0.000219	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—IGF1—prostate cancer	6.76e-06	0.000216	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—EGFR—prostate cancer	6.73e-06	0.000215	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CREBBP—prostate cancer	6.7e-06	0.000214	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—IGF1—prostate cancer	6.61e-06	0.000212	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—EGFR—prostate cancer	6.58e-06	0.000211	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—MAP2K1—prostate cancer	6.53e-06	0.000209	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PIK3CD—prostate cancer	6.49e-06	0.000208	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—PIK3CA—prostate cancer	6.43e-06	0.000206	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—SERPINE1—prostate cancer	6.42e-06	0.000205	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—MAP2K1—prostate cancer	6.39e-06	0.000204	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—KRAS—prostate cancer	6.35e-06	0.000203	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PIK3CD—prostate cancer	6.35e-06	0.000203	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—PIK3CA—prostate cancer	6.29e-06	0.000201	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—SERPINE1—prostate cancer	6.28e-06	0.000201	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—KRAS—prostate cancer	6.22e-06	0.000199	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—FGF2—prostate cancer	6.21e-06	0.000199	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—NOS3—prostate cancer	6.13e-06	0.000196	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—FGF2—prostate cancer	6.08e-06	0.000194	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—NOS3—prostate cancer	6e-06	0.000192	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—JAK2—prostate cancer	5.96e-06	0.000191	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—PIK3CA—prostate cancer	5.84e-06	0.000187	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—JAK2—prostate cancer	5.83e-06	0.000186	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—MDM2—prostate cancer	5.81e-06	0.000186	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—ERBB2—prostate cancer	5.73e-06	0.000183	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—PIK3CA—prostate cancer	5.71e-06	0.000183	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—MDM2—prostate cancer	5.69e-06	0.000182	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PIK3CB—prostate cancer	5.66e-06	0.000181	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—ERBB2—prostate cancer	5.61e-06	0.000179	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PIK3CB—prostate cancer	5.53e-06	0.000177	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CXCL8—prostate cancer	5.44e-06	0.000174	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CXCL8—prostate cancer	5.32e-06	0.00017	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CDKN1B—prostate cancer	5.31e-06	0.00017	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—AKT1—prostate cancer	5.25e-06	0.000168	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CASP3—prostate cancer	5.2e-06	0.000166	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—IL2—prostate cancer	5.2e-06	0.000166	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CDKN1B—prostate cancer	5.19e-06	0.000166	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—IL6—prostate cancer	5.17e-06	0.000165	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—AKT1—prostate cancer	5.14e-06	0.000164	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CASP3—prostate cancer	5.09e-06	0.000163	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—IL2—prostate cancer	5.08e-06	0.000163	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CCND1—prostate cancer	5.06e-06	0.000162	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—IL6—prostate cancer	5.06e-06	0.000162	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CTNNB1—prostate cancer	5.02e-06	0.00016	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CCND1—prostate cancer	4.95e-06	0.000159	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—MMP9—prostate cancer	4.92e-06	0.000157	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CTNNB1—prostate cancer	4.91e-06	0.000157	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CDKN1A—prostate cancer	4.9e-06	0.000157	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PTEN—prostate cancer	4.89e-06	0.000156	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—MMP9—prostate cancer	4.81e-06	0.000154	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CDKN1A—prostate cancer	4.79e-06	0.000153	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PTEN—prostate cancer	4.78e-06	0.000153	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—AKT1—prostate cancer	4.77e-06	0.000153	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—AKT1—prostate cancer	4.67e-06	0.000149	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—EP300—prostate cancer	4.66e-06	0.000149	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—EP300—prostate cancer	4.56e-06	0.000146	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—SRC—prostate cancer	4.53e-06	0.000145	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—SRC—prostate cancer	4.43e-06	0.000142	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—VEGFA—prostate cancer	4.42e-06	0.000141	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—STAT3—prostate cancer	4.37e-06	0.00014	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—VEGFA—prostate cancer	4.32e-06	0.000138	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—STAT3—prostate cancer	4.28e-06	0.000137	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—MYC—prostate cancer	4.06e-06	0.00013	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—TGFB1—prostate cancer	4.05e-06	0.00013	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—MYC—prostate cancer	3.97e-06	0.000127	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—EGFR—prostate cancer	3.97e-06	0.000127	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—TGFB1—prostate cancer	3.96e-06	0.000127	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—EGFR—prostate cancer	3.89e-06	0.000124	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—KRAS—prostate cancer	3.75e-06	0.00012	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—KRAS—prostate cancer	3.67e-06	0.000117	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PIK3CA—prostate cancer	3.45e-06	0.00011	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PIK3CA—prostate cancer	3.37e-06	0.000108	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—TP53—prostate cancer	3.34e-06	0.000107	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—TP53—prostate cancer	3.26e-06	0.000104	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—IL6—prostate cancer	3.05e-06	9.77e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—IL6—prostate cancer	2.99e-06	9.56e-05	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—AKT1—prostate cancer	2.82e-06	9.01e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—AKT1—prostate cancer	2.76e-06	8.82e-05	CbGpPWpGaD
